NEU 2.50% $15.59 neuren pharmaceuticals limited

Ann: Annual Report to shareholders-NEU.AX, page-13

  1. 194 Posts.
    I put the selling down to the lack of communication and delays in the TBI results.. I know you are going to say April but it is now late April and still no news. I was expecting something by now and the wait is frustrating. I am not saying the delay means anything negative but it does test investors nerves.
    The company may be in a position where it cannot communicate more directly for commercial reasons.
    Whatever it is we will find out very soon
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.